![Tobin Schilke](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Tobin Schilke
Directeur Financier/CFO chez
CRINETICS PHARMACEUTICALS, INC.
Fortune : 253 152 $ au 31/05/2026
Profil
Tobin C.
Schilke is currently Chief Financial Officer at Crinetics Pharmaceuticals, Inc. since 2025.
Formerly, Chief Financial Officer at Revance Therapeutics, Inc. from 2018 to 2025.
Chief Financial Officer at Achaogen, Inc. from 2016 to 2018.
Chief Financial Officer & Executive Director at Roche Products Ltd. from 2012 to 2016.
Director-Commercial Financial Planning & Analysis at Genentech, Inc. from 2012 to 2014.
Education includes undergraduate studies at Lafayette College, graduate studies at the University of California, Berkeley, and an MBA from Johnson Graduate School of Management.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 20/04/2026 | 7 121 ( 0,01% ) | 253 152 $ | 31/05/2026 |
Postes actifs de Tobin Schilke
| Sociétés | Poste | Début |
|---|---|---|
| CRINETICS PHARMACEUTICALS, INC. | Directeur Financier/CFO | 28/02/2025 |
Anciens postes connus de Tobin Schilke
| Sociétés | Poste | Fin |
|---|---|---|
| REVANCE THERAPEUTICS, INC. | Directeur Financier/CFO | 04/02/2025 |
| ACHAOGEN | Directeur Financier/CFO | 01/10/2018 |
Roche Products Ltd.
 Roche Products Ltd. Pharmaceuticals: MajorHealth Technology Manufactures diagnostic, diabetes and pharmaceutical products | Directeur Financier/CFO | 01/06/2016 |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Corporate Officer/Principal | 01/08/2014 |
Formation de Tobin Schilke
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
44
Relations au 1er degré
8
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 8 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Health Technology |
Achaogen, Inc.
 Achaogen, Inc. Pharmaceuticals: MajorHealth Technology Operates as a a biopharmaceutical company, which engages in the research, development, and commercialization of antibacterial treatments for multi-drug resistant (MDR) gram-negative infections | Health Technology |
Revance Therapeutics, Inc.
 Revance Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops drugs for esthetics, skincare and therapeutics | Health Technology |
Lafayette College
 Lafayette College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of California, Berkeley
 University of California, Berkeley Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Johnson Graduate School of Management
 Johnson Graduate School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Roche Products Ltd.
Roche Products Ltd. Pharmaceuticals: MajorHealth Technology Manufactures diagnostic, diabetes and pharmaceutical products | Health Technology |
Crinetics Pharmaceuticals, Inc.
 Crinetics Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets therapeutics for endocrine-related diseases | Health Technology |
